New drug expands treatment opportunities for rheumatoid arthritis
In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least…
MedUni Vienna
New biomarker can predict MS severity
It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this…
New guidelines for the diagnosis and treatment of brain metastases
Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two…
Vaccine supports immune response in immunosuppressed
Research from MedUni Vienna demonstrates that SARS-CoV-2 vaccination supports immune response in immunosuppressed patients Patients under immunosuppressive therapy can still…
Lung cancer immunotherapy treatment
Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of…
Chronic inflammatory liver disease
Chronic inflammatory liver disease: cell stress mechanisms identified as prognostic factor: PSC is a rare disease with a poor prognosis…
How inflammatory signalling molecules contribute to carcinogenesis
How inflammatory signalling molecules contribute to carcinogenesis: A team of MedUni Vienna researchers led by Johannes A. Schmid at the…
Latest international brain tumour research
New findings about brain tumour development could lead to more effective treatment. For the first time in the world, an…